LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 7.01 | 17.25 | 722 | 389 | 1.8537 | 1.2942 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 7.01 | 17.25 | 3 | 389 | 0.0077 | -0.3223 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 7.01 | 17.25 | 805 | 389 | 2.0668 | 1.3504 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 8.98 | 17.25 | 1 | 445 | 0.0022 | -0.4552 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 8.98 | 17.25 | 785 | 445 | 1.7638 | 1.2573 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 8.98 | 17.25 | 4 | 445 | 0.0090 | -0.2678 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 8.98 | 17.25 | 856 | 445 | 1.9233 | 1.2993 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 10.95 | 17.25 | 4 | 471 | 0.0085 | -0.2638 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 10.95 | 17.25 | 819 | 471 | 1.7367 | 1.2452 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 10.95 | 17.25 | 9 | 471 | 0.0191 | -0.1275 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 10.95 | 17.25 | 920 | 471 | 1.9509 | 1.3006 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 12.91 | 17.25 | 3 | 494 | 0.0061 | -0.3032 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 12.91 | 17.25 | 823 | 494 | 1.6631 | 1.2215 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 12.91 | 17.25 | 17 | 494 | 0.0344 | -0.0030 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 12.91 | 17.25 | 943 | 494 | 1.9056 | 1.2849 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 14.88 | 17.25 | 2 | 534 | 0.0037 | -0.3528 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 14.88 | 17.25 | 874 | 534 | 1.6354 | 1.2088 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 14.88 | 17.25 | 29 | 534 | 0.0543 | 0.1106 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 14.88 | 17.25 | 971 | 534 | 1.8169 | 1.2562 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 16.85 | 17.25 | 2 | 655 | 0.0031 | -0.3367 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 16.85 | 17.25 | 909 | 655 | 1.3866 | 1.1285 | MN20160310_N02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 16.85 | 17.25 | 150 | 655 | 0.2288 | 0.5100 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 16.85 | 17.25 | 1039 | 655 | 1.5849 | 1.1834 | MN20160310_N02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 18.82 | 17.25 | 3 | 800 | 0.0037 | -0.2709 | MN20160310_N02 | C22 |